Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Reexamination Certificate
2007-04-27
2010-12-28
Mondesi, Robert B (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
Reexamination Certificate
active
07858097
ABSTRACT:
The present invention providesListeriastrains that express a heterologous antigen and a metabolic enzyme, and methods of generating same.
REFERENCES:
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 6099848 (2000-08-01), Frankel et al.
patent: 6767542 (2004-07-01), Paterson et al.
patent: 2005/0118184 (2005-06-01), Paterson et al.
patent: WO 99/25376 (1999-05-01), None
patent: WO 01/72329 (2001-10-01), None
Bruhn et al., “Listeriaas a vaccine vector”, Microbes and Infection 9, 2007, 1226-1235.
Peters et al., “Enhancing the immunogenicity of bioengineeredListeriamonocytogenes by passaging through live animal hosts.” Vaccine, 21: 1187-1194, 20O3.
Alexander et al., 1993, “Characterization of an aromatic amino acid-dependentListeria monocytogenesmutant: attenuation, persistence, and ability to produce protective immunity in mice”, Infection and Immunity 61:2245-2248.
Abachin et al., 2002, “Formation of D-alanyi-iipoteichoic acid is required for adhesion and virulence ofListeria monocytogenes”, Mol. Microbiol. 43 1-14.
Brundage et al., 1993, “Expression and phosphorylation of theListeria monocytogenesActA protein in mammalian cells”, Proc. Natl. Acad. Sci. USA 90:11890-11894.
Bron et al., 2002, “Use of theairGene as a Food-Grade Selection Market in Lactic Acid Bacteria”, Applied and Environmental Microbiology, 68(11):5563-5570.
Brown et al., 1979, “Chemical Synthesis and Cloning of a Tyrosine tRNA Gene”, Meth Enzymol. 68-109-151.
Beaucage et al., 1981, “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates for Deoxypoylnucleotide Synthesis”, Tetra. Lett. 22:1859-1862.
Camilli et al., 1992, “Dual Roles of plcA inListeria monocytogenesPathogenesis”, Mol. Microbrol. 8:143-157.
Camilli et al., 1991, “Listeria monocytogenesmutants lacking phosphatidylinositol-specific phospholipase C are avirulent”, J. Exp. Med., 173:751-754.
Cenatiempo. 1986, “Prokaryotic Gene Expression In Vitro. Transcription—Translation Coupled Systems”, Biochimie 68:505-516.
Dermer, 1994, “Another Anniversary for the War on Cancer”, Bio/Technology , vol. 12, p. 320.
De Boer et al , 1989, “A division inhibitor and a topological specificity factor coded for by the minicell locus determine proper placement of the division septum inE.coli”, Cell 56:641-649.
Frankel et al., 1995. “Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by usingListeria monocytogenesas a live vaccine vector”, J. Immunol. 155:4775-4782.
Freshbey, 1983. “Culture of Animal Cells, A Manual of Basic Technique”, Alan R, Liss. Inc. pp. 3-4.
Glenting et al , 2002. “A Plasmid Selection System inLactococcus Lactisand Its Use for Gene Expression inL. lactisand Human Kidney Fibroblasts”, Applied and Environmental Microbiology. 68:5051-5056.
Gunn et al., 2001, “TwoListeria monocytogenesVaccine Vectors That Expresses Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16” J. Immunol. 167:6471-6479.
Gilman et al., 1984, “Isolation of sigma-28-specific promoters fromBacillus subtilisDNA”, Gene 32:11-20.
Glick, 1987. “Factors affecting the expression of foreign proteins inEscherichia coli”, J. Ind. Microbiol. 1.277-282.
Gottesman, 1984. “Bacterial regulation: global regulatory networks”, Ann. Rev. Genet. 18:415-442.
Gura. 1997. “Systems for Identifying New Drugs Are Often Faulty”, Science 278:1041-1042.
Greenspan et al., 1929. “Defining epitopes: It's not easy as it seems”, Nature Biotechnology 7:936-937.
Harris et al , 1986, “Molecular basis for heterogeneity of the human p53 protein”, Mol. Cell. Biol. 6:4650-4656.
Ikonomidis et al., 1994, “Delivery of a viral antigen to the class I processing and presentation pathway byListeria monocytogenes”, J Exp. Med. 180: 2209-2218.
International Search Report of Application No. PCT/US08/04861 issued Sep. 29, 2008.
International Search Report of Application No. PCT/US05/28896 issued Oct. 26, 2006.
International Search Report of Application No. PCT/US05/28895 issued Jul. 5, 2006.
Kohler, et al., 1991, “Expression of the iap gene coding for protein p60 ofListeria monocytogenesis controlled on the posttranscriptional level”, J. Bacteriol 173: 4668-4674.
Leitner et al., 2000, “DNA and RNA-based vaccines: principles, progress and prospects”, Vaccine 18:765-777.
Lauer et al., 2002, “Construction, Characterization, and Use of TwoListeria monocytogenesSite-Specific Phage Integration Vectors”, J. Bacteriol. 184:4177-4186.
Mata et al., 2001, “Evaluation of a recombinantListeria monocytogenesexpressing an HIV protein that protects mice against viral challenge”, Vaccine 19:1435-1445.
Miller et al., 1995, “Targeted vectors for gene therapy”, FASEB J., 9:190-199.
Narang et al., 1979, “Improved Phosphotriester Method for the Synthesis of Gene Fragments”, Meth. Enzymol., 68:90-99.
Pucci et al., 1995, “Staphylococcus haemolyticuscontains two D-glutamic acid biosynthetic activities, a glutamate racemase and a D-amino acid transaminase”, J. Bacteriol. 177. 336-342.
Pilgrim et al., 2003, “Bactofection of mammalian cells byListeria monocytogenes: improvement and mechanism of DNA delivery”, Gene Ther., 10(24):2036-45.
Restifo et al., 2000, “The promise of nucleic acid vaccines”, Gene Therapy, 7.89-92.
SIZEMORE et al., 1995, “AttenuatedShigellaas a DNA Delivery Vehicles for DNA-Mediated Immunization”, Science 270:299-302.
Strych et al., 2002, “Mutant analysis shows that alanine racemases fromPseudomonas aeruginosaandEscherichia coliare dimeric”, J. Bacteriol. 184:4321-4325.
Thompson et al., 1998, “Pathogenicity and immunogenicity of aListeria monocytogenesstrain that requires D-alanine for growth”, Infec Immun 66: 3552-3561.
Tauch et al., 2002, “The alanine racemase geneairis an alternative to antibiotic resistance genes in cloning systems for industrialCorynebacterium glutamicumstrains”, J. Biotechnol 99:79-91.
Ulmanen et al., 1985, “Transcription and translation of foreign genes inBacillus subtilisby the aid of a secretion vector”, J. Bacteriol., 162:176-182.
Verch et al., Nov. 2004, “Listeria monocytogenes-Based Antibiotic Resistance Gene-Free Antigen Delivery System Applicable to Other Bacterial Vectors and DNA Vaccines” , Infection and Immunity, p. 6418-6425.
Wirth et al., 1986, “Highly efficient protoplast transformation system forStreptococcus faecalisand a newEscherichia coli -S faecalisshuttle vector”, J. Bacteriol. 165(3):831-6.
Ward et al., 1986, “Construction and Characterisation of a Series of Multi-copy Promoter-probe Plasmid Vectors for Streptomyces Using the Aminoglycoside Phosphotransferase Gene From Tn5 as Indicator”, Mol Gen. Genet. 203:468-478.
Yaghmai et al., 2002 “Optimized regulation of gene expression using artificial transcription factors”, Mol. Therapy, 5:685-694.
http://www.biology-text.com/defintion.php?word=Pest÷sequence.accessed Jan. 22. 2007.
Rechsteiner et al. “PEST sequences and regulation by proteolysis”, Trends Biochem Sci. Jul. 1996;21(7):267-71.
Paterson Yvonne
Verch Thorsten
Cohen Mark S.
Gangle Brian J
Mondesi Robert B
Pearl Cohen Zedek Latzer LLP
The Trustees of the University of Pennsylvania
LandOfFree
Antibiotic resistance free Listeria strains and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibiotic resistance free Listeria strains and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic resistance free Listeria strains and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4188744